Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI

NCT02787317 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1770

Enrollment

OTHER

Sponsor class

Conditions

Coronary Disease

Interventions

DRUG: bivalirudin
DRUG: Heparin

Sponsor

Chinese PLA General Hospital